₹386.1
▼ -1.01 -0.26%
17 Jul 2026
NSE Listed
SMS Pharmaceuticals Ltd. (SMSPHARMA)
Volume: 1,39,223Avg Vol 1W: 3,26,653Avg Vol 1M: 6,96,040.2552W Range:₹207.99₹447.8
Key Ratios
Checked 6h agoMarket Cap₹3,625 Cr
Current Price₹386.1
Previous Close₹387.11
High / Low (52w)₹447.8 / ₹207.99
Volume1,39,223
Avg Vol (1W)3,26,653
Avg Vol (1M)6,96,040.25
Stock P/E108.13
Book Value₹83.91
Dividend Yield10%
ROE12.98%
ROA6.46%
Revenue (TTM)₹789 Cr
Revenue Growth10.4%
Profit Margin11.5%
Total Debt₹139 Cr
Shares Outstanding9 Cr
Face Value₹1
EPS (TTM)₹10.89
P/B4.61
Debt / Equity0.5
50 DMA₹389.4
200 DMA₹351.48
Day change-0.26%
Price Chart
₹386.1▲ 55.75% · 1Y
2025-07-172026-07-16
20-day avg volume: 7.0L shares
Pros
- Pays a dividend yield of 10.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 108.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹164 Cr | ₹197 Cr | ₹173 Cr | ₹248 Cr | ₹196 Cr | ₹242 Cr | ₹210 Cr | ₹238 Cr |
| EBITDA | ₹27 Cr | ₹24 Cr | ₹27 Cr | ₹34 Cr | ₹30 Cr | ₹40 Cr | ₹37 Cr | ₹32 Cr |
| Net Profit | ₹16 Cr | ₹14 Cr | ₹18 Cr | ₹20 Cr | ₹20 Cr | ₹25 Cr | ₹23 Cr | ₹33 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹465 Cr | ₹468 Cr | ₹417 Cr | ₹567 Cr | ₹525 Cr | ₹527 Cr | ₹714 Cr | ₹789 Cr |
| EBITDA | ₹76 Cr | ₹74 Cr | ₹63 Cr | ₹102 Cr | ₹87 Cr | ₹27 Cr | ₹90 Cr | ₹111 Cr |
| Net Profit | ₹32 Cr | ₹40 Cr | ₹32 Cr | ₹63 Cr | ₹62 Cr | ₹-7 Cr | ₹50 Cr | ₹69 Cr |
| EPS | 3.75 | 4.73 | 3.73 | 7.39 | 7.35 | -0.83 | 5.89 | 8.16 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹503 Cr | ₹559 Cr | ₹608 Cr | ₹812 Cr | ₹860 Cr | ₹880 Cr | ₹1,034 Cr | ₹1,153 Cr |
| Total Liabilities | ₹218 Cr | ₹237 Cr | ₹260 Cr | ₹402 Cr | ₹389 Cr | ₹419 Cr | ₹498 Cr | ₹513 Cr |
| Equity | ₹284 Cr | ₹322 Cr | ₹348 Cr | ₹411 Cr | ₹470 Cr | ₹461 Cr | ₹536 Cr | ₹640 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹43 Cr | ₹63 Cr | ₹52 Cr | ₹106 Cr | ₹60 Cr | ₹27 Cr | ₹66 Cr | ₹102 Cr |
| Investing | ₹-17 Cr | ₹-35 Cr | ₹-43 Cr | ₹-152 Cr | ₹-27 Cr | ₹-30 Cr | ₹-52 Cr | ₹-123 Cr |
| Financing | ₹-15 Cr | ₹-13 Cr | ₹-2 Cr | ₹92 Cr | ₹-12 Cr | ₹-32 Cr | ₹31 Cr | ₹47 Cr |
| Free Cash Flow | ₹43 Cr | ₹63 Cr | ₹52 Cr | ₹107 Cr | ₹60 Cr | ₹27 Cr | ₹66 Cr | ₹102 Cr |
Shareholding
Promoter 68.07% Institutions 3.48% Public 28.45%
Efficiency & Working Capital
ROCE12.1%
Interest Coverage6
Dividend Payout—
Debtor Days89 d
Inventory Days124 d
Payable Days50 d
Cash Conversion Cycle163 d
Working Capital Days213 d
Shareholding Details
As of 2026-06-30
Promoter68.1%
FII0.6%
DII2.8%
Institutions3.5%
Public28.5%
Promoter Pledge18%
No. of Shareholders31,489
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 64.3% | 64.3% | 64.7% | 64.7% | 64.7% | 64.7% | 66.3% | 66.3% | 68.1% | 68.1% | 68.1% | 68.1% |
| FIIs | 0.6% | 0.6% | 0.2% | 0.2% | 0.5% | 0.3% | 0.1% | 0% | 0.3% | 0% | 0.3% | 0.6% |
| DIIs | 0% | 0% | 2% | 2.1% | 2.5% | 2.5% | 2.4% | 3% | 2.9% | 3.2% | 3% | 2.8% |
| Public | 35.1% | 35.1% | 33.2% | 33% | 32.3% | 32.5% | 31.2% | 30.7% | 28.8% | 28.7% | 28.6% | 28.5% |
| Promoter Pledge | 10.7% | 19.5% | 19.4% | 19.4% | 19.4% | 19.4% | 37.6% | 37.6% | 34.7% | 18% | 18% | 18% |
| No. of Shareholders | 25,246 | 25,341 | 30,140 | 31,780 | 33,136 | 34,973 | 35,332 | 33,652 | 34,157 | 34,378 | 32,397 | 31,489 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ramesh Babu Potluri | Shareholding of Promoter and Promoter Group | 19.4% | 1.82 Cr |
| Vamsi Krishna Potluri | Shareholding of Promoter and Promoter Group | 16.9% | 1.58 Cr |
| Hima Bindu Potluri | Shareholding of Promoter and Promoter Group | 16% | 1.50 Cr |
| Potluri Infra Projects Llp | Shareholding of Promoter and Promoter Group | 9.5% | 88,46,420 |
| Trilok Potluri | Shareholding of Promoter and Promoter Group | 5% | 46,88,000 |
| Quant Mutual Fund - Quant Small Cap Fund | Public Shareholding | 2.8% | 26,32,409 |
| Aniruddh Mundra | Public Shareholding | 2% | 18,82,971 |
| Venkata Subbaraju Penmatsa Huf | Public Shareholding | 1.8% | 17,00,000 |
| Sudeepthi Gopineedi | Public Shareholding | 1.4% | 13,20,170 |
| Venkata Praveen Talluri | Public Shareholding | 1.4% | 13,20,170 |
| Potluri Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 1.2% | 11,20,320 |
| Tvt Infracon Llp | Shareholding of Promoter and Promoter Group | 0.1% | 1,00,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Hima Bindu Potluri | 30,00,000 | 20% | 2026-06-30 |
| Ramesh Babu Potluri | 0 | 0% | 2026-06-30 |
| Vamsi Krishna Potluri | 0 | 0% | 2026-06-30 |
| Trilok Potluri | 0 | 0% | 2026-06-30 |
| Potluri Laboratories Private Limited | 11,20,320 | 100% | 2026-06-30 |
| Potluri Infra Projects Llp | 73,46,420 | 83% | 2026-06-30 |
| Tvt Infracon Llp | 0 | 0% | 2026-06-30 |
| Quant Mutual Fund - Quant Small Cap Fund | 0 | 0% | 2026-06-30 |
| Venkata Subbaraju Penmatsa Huf | 0 | 0% | 2026-06-30 |
| Sudeepthi Gopineedi | 0 | 0% | 2026-06-30 |
| Venkata Praveen Talluri | 0 | 0% | 2026-06-30 |
| Aniruddh Mundra | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| P Ramesh Babu | Chairman / Executive Director / Managing Director | 2025 |
| Sarvepalli Srinivas | Independent Non Exe. Director | 2025 |
| Shravan Kudaravalli | Independent Non Exe. Director | 2025 |
| G Suresh Kumar | Independent Non Exe. Director | 2025 |
| Shanti Sree Bolleni | Independent Non Exe. Director | 2025 |
| Trilok Potluri | Non-Exec & Non-Independent Dir | 2025 |
| Sunkara Venkata Satya Shiva Prasad | Non-Exec & Non-Independent Dir | 2025 |
| Vamsi Krishna potluri | Executive Director | 2025 |
| Thirumalesh Tumma | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing and Sale of Active Ph | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Exports | ₹326 Cr | 62.4% |
| Deemed Exports | ₹16 Cr | 3% |
| Domestic | ₹178 Cr | 34.1% |
| Export Incentives | ₹2 Cr | 0.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 12 | 9 | 9 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-22 | ₹0.4 (40%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 59 | 0 | 11 | 17 | 88 |
| 2025 | 0 | 19 | 0 | 11 | 17 | 48 |
| 2025 | 0 | 40 | 0 | 0 | 0 | 40 |
Insider / Designated-Person Trades
30 recent disclosure(s)
P. Deepthi SriDisposal · 5,000
P. ManideepDisposal · 1,000
P. ManideepDisposal · 1,500
G. Suresh KumarDisposal · 5,000
P. Srinivasa RaoDisposal · 3,007
P. Srinivasa RaoDisposal · 2,000
Substantial Acquisitions (SAST)
30 disclosure(s)
Release Of Pledge03/11/2025 · —
Pledge Released03/11/2025 · —
Pledge Released03/11/2025 · —
Pledge30/06/2025 · —
Pledge Released30/06/2025 · —
Pledge Released30/06/2025 · —
Company Information
Incorporated1987
ChairmanP Ramesh Babu
AuditorSuryanarayana & Suresh
Investor Email[email protected]; [email protected];
📍 8th Floor Trendset Jayabheri, Connect Kondapur Serilingampal, Hyderabad, Telangana, 500084
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search